Dolby Laboratories, Inc.
DLB
$75.34
$0.360.48%
NYSE
| 03/28/2025 | 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.03% | 2.71% | -2.00% | -2.17% | -0.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.03% | 2.71% | -2.00% | -2.17% | -0.75% |
| Cost of Revenue | -1.10% | -0.64% | -7.91% | -7.87% | -0.49% |
| Gross Profit | 4.71% | 3.16% | -1.22% | -1.39% | -0.78% |
| SG&A Expenses | 2.35% | 1.68% | -1.30% | 0.43% | 3.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.65% | -0.14% | -2.69% | -0.71% | 3.34% |
| Operating Income | 18.66% | 15.01% | 0.72% | -7.72% | -15.23% |
| Income Before Tax | 34.34% | 37.59% | 24.97% | -3.76% | -20.92% |
| Income Tax Expenses | 32.64% | 28.61% | -0.51% | -11.58% | -21.27% |
| Earnings from Continuing Operations | 34.72% | 39.53% | 31.08% | -1.88% | -20.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -27.80% | -41.19% | -152.13% | -984.39% | -520.29% |
| Net Income | 34.79% | 39.52% | 30.48% | -3.09% | -21.46% |
| EBIT | 18.66% | 15.01% | 0.72% | -7.72% | -15.23% |
| EBITDA | 15.80% | 10.85% | -1.48% | -7.42% | -13.12% |
| EPS Basic | 34.45% | 39.57% | 30.88% | -2.69% | -20.56% |
| Normalized Basic EPS | 14.18% | 13.37% | 6.70% | 1.27% | -5.23% |
| EPS Diluted | 34.63% | 40.34% | 31.01% | -2.74% | -20.68% |
| Normalized Diluted EPS | 14.60% | 13.95% | 6.75% | 1.12% | -5.55% |
| Average Basic Shares Outstanding | 0.15% | -0.04% | -0.24% | -0.51% | -1.69% |
| Average Diluted Shares Outstanding | -0.32% | -0.59% | -0.42% | -0.34% | -1.23% |
| Dividend Per Share | 10.26% | 10.53% | 10.81% | 11.11% | 10.38% |
| Payout Ratio | -0.18% | -0.21% | -0.15% | 0.13% | 0.37% |